| 영문 | abuse | 한글 | 남용 |
|---|---|---|---|
| 설명 | 의학적 상식-법규 사회적 관습으로부터 일탈하여 쾌락을 추구하기 위하여 약물을 사용하거나 과잉으로 사용하는 행위를 말한다. 따라서 법적규제의 대상이 되는 마약류를 사용하는 것과 법적 규제의 대사에 포함되어 있지 않은 약물이라도 환각목적으로 사용할 경우도 포함된다. |
||
| 영문 | opioid | 한글 | 아편유사제 |
|---|---|---|---|
| 설명 | 1. 아편제제와 같은 작용을 가진 합성마약으로서 아편유도체가 아닌 것. 종류로는 heroin, meperidine, dihydromorphine(Dilaudid), methadone 등이 있다. 2. 세포막의 아편제제 수용체와 상호작용함으로써 아편제제와 같은 효과를 나타내는 천연산 펩티드. |
||
| POP | diphosphate group; pain on palpation; paroxypropione; persistent occipitoposterior [fetal position];... |
|---|---|
| AA/AD | alcohol abuse/alcohol dependence |
| AC | abdominal circumference; abdominal compression; absorption coefficient; abuse case; acetate; acetylc... |
| ADAMHA | Alcohol, Drug Abuse, and Mental Health Administration |
| ADAU | adolescent drug abuse unit |
| OR | 1-opioid receptor |
|---|---|
| ADAMHA | Alcohol, Drug Abuse, and Mental Health Administration |
| CAP | Child Abuse Potential |
| CSA | Child sexual abuse |
| CSA | Childhood sexual abuse |
| analgesics, opioid | Narcotic or opioid substances, synthetic or semisynthetic agents producing profound analgesia, drowsiness, and changes in mood. Mood changes may be pleasurable, therefore creating a potential for the abuse of these agents; the prototype of these is morphine to which all other analgesics are compared. (12 Dec 1998) |
|---|---|
| receptors, opioid | Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behaviour of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. (12 Dec 1998) |
| receptors, opioid, delta | A class of opioid receptors recognised by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins. (12 Dec 1998) |
| receptors, opioid, kappa | A class of opioid receptors recognised by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins. (12 Dec 1998) |
| receptors, opioid, mu | A class of opioid receptors recognised by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. (12 Dec 1998) |
| mixed opioid agonist-antagonist | <pharmacology> A compound that has an affinity for two or more types of opioid receptors and blocks opioid effects on one receptor type while producing opioid effects on a second receptor type. (13 Nov 1997) |
| opioid | Originally, a term denoting synthetic narcotics resembling opiates but increasingly used to refer to both opiates and synthetic narcotics. (05 Mar 2000) |
| opioid agonist | <pharmacology> Any morphine-like compound that produces bodily effects including pain relief, sedation, constipation and respiratory depression. (16 Dec 1997) |
| opioid antagonists | Agents such as naloxone and naltrexone which have high affinity for opiate receptors but do not activate these receptors. These drugs block the effects of exogenously administered opioids such as morphine, heroin, meperidine, and methadone, or of endogenously released endorphins and enkephalins. (05 Mar 2000) |
| opioid partial agonist | <pharmacology> A compound that has an affinity for and stimulates physiologic activity at the same cell receptors as opioid agonists but that produces only a partial (i.e., submaximal) bodily response. (16 Dec 1997) |
| opioid peptides | The endogenous peptides with opiate-like activity. The three major classes currently recognised are the enkephalins, the dynorphins, and the endorphins. Each of these families derives from different precursors, proenkephalin, prodynorphin, and pro-opiomelanocortin, respectively. There are also at least three classes of opioid receptors, but the peptide families do not map to the receptors in a simple way. (12 Dec 1998) |
| opioid receptor | <pharmacology> A membrane protein, widely distributed in animal cells, but especially in the brain (enkephalin receptors) and gut. The natural ligands are the opiate peptide neurotransmitters, but the name is given because opiates are potent agonists that occupy the receptors and mimic the action of the natural transmitters. (18 Nov 1997) |
| opioid-related disorders | Disorders related or resulting from abuse or mis-use of opioids. (12 Dec 1998) |
| abuse | 1. Improper treatment or use; application to a wrong or bad purpose; misuse; as, an abuse of our natural powers; an abuse of civil rights, or of privileges or advantages; an abuse of language. "Liberty may be endangered by the abuses of liberty, as well as by the abuses of power." (Madison) 2. Physical ill treatment; injury. "Rejoice . . . at the abuse of Falstaff." 3. A corrupt practice or custom; offense; crime; fault; as, the abuses in the civil service. "Abuse after disappeared without a struggle." (Macaulay) 4. Vituperative words; coarse, insulting speech; abusive language; virulent condemnation; reviling. "The two parties, after exchanging a good deal of abuse, came to blows." (Macaulay) 5. Violation; rape; as, abuse of a female child. "Or is it some abuse, and no such thing?" (Shak) Abuse of distress, a wrongful using of an animal or chattel distrained, by the distrainer. Synonym: Invective, contumely, reproach, scurrility, insult, opprobrium. Abuse, Invective. Abuse is generally prompted by anger, and vented in harsh and unseemly words. It is more personal and coarse than invective. Abuse generally takes place in private quarrels; invective in writing or public discussions. Invective may be conveyed in refined language and dictated by indignation against what is blameworthy. Origin: F. Abus, L. Abusus, fr. Abuti. See Abuse. Source: Websters Dictionary (01 Mar 1998) |
| marijuana abuse | The excessive use of marijuana with associated psychological symptoms and impairment in social or occupational functioning. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|